MedPath

CARDIFF UNIVERSITY

🇬🇧United Kingdom
Ownership
-
Established
1883-01-01
Employees
6.1K
Market Cap
-
Website
https://cardiff.ac.uk/

Clinical Trials

168

Active:84
Completed:63

Trial Phases

5 Phases

Phase 1:57
Phase 2:17
Phase 3:2
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (153 trials with phase data)• Click on a phase to view related trials

Not Applicable
72 (47.1%)
Phase 1
57 (37.3%)
Phase 2
17 (11.1%)
Phase 4
4 (2.6%)
Phase 3
2 (1.3%)
phase_1_2
1 (0.7%)

Sensor-based Physiotherapy Intervention with Virtual Reality

Not Applicable
Recruiting
Conditions
Knee Osteoarthritis
First Posted Date
2024-10-14
Last Posted Date
2024-10-14
Lead Sponsor
Cardiff University
Target Recruit Count
50
Registration Number
NCT06639867
Locations
🇬🇧

Cardiff University School of Healthcare Sciences, Cardiff, United Kingdom

🇬🇧

University Hospital of Wales, Cardiff, United Kingdom

fertiShare Evaluation

Not Applicable
Recruiting
Conditions
Infertility Assisted Reproductive Technology
First Posted Date
2024-09-19
Last Posted Date
2025-07-29
Lead Sponsor
Cardiff University
Target Recruit Count
420
Registration Number
NCT06587360
Locations
🇬🇧

The Newcastle Upon Tyne Hospitals Nhs Foundation Trust, Newcastle, Newcastle upon Tyne, United Kingdom

🇬🇧

Aberdeen Fertility Centre, Aberdeen, United Kingdom

🇬🇧

King's Fertility, London, United Kingdom

and more 2 locations

Evaluating an ACT Self-help Book for University Students

Not Applicable
Active, not recruiting
Conditions
Well-Being, Psychological
First Posted Date
2024-01-16
Last Posted Date
2024-07-18
Lead Sponsor
Cardiff University
Target Recruit Count
8
Registration Number
NCT06207214
Locations
🇬🇧

Based at Cardiff University (study to be completed remotely), Cardiff, United Kingdom

Mindful Parenting - A Single Case Experimental Design Study

Not Applicable
Recruiting
Conditions
Parenting
Neurofibromatoses
Limb Difference
Cleft Lip and Palate
Skin Condition
Craniofacial
Alopecia
First Posted Date
2023-03-22
Last Posted Date
2023-03-22
Lead Sponsor
Cardiff University
Target Recruit Count
12
Registration Number
NCT05779527
Locations
🇬🇧

Cardiff University, Cardiff, United Kingdom

Self-help Booklets for Depression in Adults With Pulmonary Hypertension.

Not Applicable
Completed
Conditions
Depression
Pulmonary Hypertension
First Posted Date
2023-02-14
Last Posted Date
2024-08-20
Lead Sponsor
Cardiff University
Target Recruit Count
68
Registration Number
NCT05726669
Locations
🇬🇧

Cardiff University - however recruitment is done electronically, Cardiff, United Kingdom

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

News

Draig Therapeutics Emerges from Stealth with $140M to Advance Novel Neuropsychiatric Therapies

Draig Therapeutics launched with $140 million in Series A funding to develop next-generation treatments for neuropsychiatric disorders, marking the largest commercial investment in Welsh research to date.

New Bone Marrow Test Could Double Survival Rates for Acute Myeloid Leukemia Patients

A groundbreaking UK trial has developed a highly sensitive bone marrow test that can detect returning Acute Myeloid Leukemia up to three months earlier than standard blood tests, potentially doubling survival rates for some patients.

Low-Dose Apixaban Proves Effective and Safer for Extended Cancer-Related VTE Prevention

The API-CAT trial demonstrated that reduced-dose apixaban (2.5mg twice daily) was noninferior to full-dose (5mg twice daily) for preventing recurrent venous thromboembolism in cancer patients requiring extended anticoagulation.

Psoriasis Drug Ustekinumab Shows Promise in Preserving Insulin Production in Young Type 1 Diabetes Patients

A clinical trial found that ustekinumab, a drug currently used for psoriasis, preserved insulin production in young type 1 diabetes patients, with C-peptide levels 49% higher after one year compared to placebo.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.